Literature DB >> 8947480

Regulation of natural killer cell-mediated cytotoxicity by serine/threonine phosphatases: identification of a calyculin A-sensitive serine/threonine kinase.

A Bajpai1, Z Brahmi.   

Abstract

We have recently reported that Ser/Thr phosphatases play a key role in regulating natural killer (NK) cell lytic activity and that calyculin A and okadaic acid affect this activity differently [Bajpai and Brahmi (1994) J. Biol. Chem. 269, 18864-18869]. Here, we investigate a mechanism that might account for this differential action of calyculin A and okadaic acid on NK cells. Calyculin A specifically inhibited the lytic activity of YT-INDY, an NK-like cell line, and hyperphosphorylated 60 and 78 kDa proteins. The kinetics of appearance of these two proteins was correlated with the loss of lytic activity. In contrast, okadaic acid did not significantly affect either of these activities. The 78 kDa protein is localized in the cytosolic compartment whereas the 60 kDa protein is distributed equally between the membrane and the cytosolic fractions. Both proteins display a kinase activity and are phosphorylated mainly at serine and threonine residues but not at tyrosine residues. The activation of these kinases is specific to calyculin A treatment; it is independent of protein kinase C, protein kinase A, Ca2+, phosphotyrosine phosphatase and protein synthesis de novo. In conclusion, we have demonstrated that calyculin A, but not okadaic acid, hyper-phosphorylates two proteins with Ser/Thr kinase activity, thus explaining the differential regulation of NK cells by these two Ser/Thr phosphatase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947480      PMCID: PMC1217910          DOI: 10.1042/bj3200153

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line.

Authors:  A H Montel; P A Morse; Z Brahmi
Journal:  Cell Immunol       Date:  1995-01       Impact factor: 4.868

2.  A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel.

Authors:  I Kameshita; H Fujisawa
Journal:  Anal Biochem       Date:  1989-11-15       Impact factor: 3.365

Review 3.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

4.  TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).

Authors:  J Yodoi; K Teshigawara; T Nikaido; K Fukui; T Noma; T Honjo; M Takigawa; M Sasaki; N Minato; M Tsudo
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics.

Authors:  C Bialojan; A Takai
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

7.  Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase.

Authors:  N G Anderson; J L Maller; N K Tonks; T W Sturgill
Journal:  Nature       Date:  1990-02-15       Impact factor: 49.962

8.  Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.

Authors:  M Suganuma; H Fujiki; H Furuya-Suguri; S Yoshizawa; S Yasumoto; Y Kato; N Fusetani; T Sugimura
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

9.  Specific binding of okadaic acid, a new tumor promoter in mouse skin.

Authors:  M Suganuma; M Suttajit; H Suguri; M Ojika; K Yamada; H Fujiki
Journal:  FEBS Lett       Date:  1989-07-03       Impact factor: 4.124

Review 10.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.